Athira Pharma Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Athira Pharma's estimated annual revenue is currently $7.6M per year.(i)
  • Athira Pharma's estimated revenue per employee is $110,072
  • Athira Pharma's current valuation is $412.7M. (January 2022)

Employee Data

  • Athira Pharma has 69 Employees.(i)
  • Athira Pharma grew their employee count by 38% last year.

Athira Pharma's People

NameTitleEmail/Phone
1
CFO & CBOReveal Email/Phone
2
VP Finance and Accounting Reveal Email/Phone
3
VP, Head Biometrics & Data ManagementReveal Email/Phone
4
VP Regulatory AffairsReveal Email/Phone
5
VP, Program and Portfolio ManagementReveal Email/Phone
6
SVP CMC and Technical OperationsReveal Email/Phone
7
General CounselReveal Email/Phone
8
VP Clinical OperationsReveal Email/Phone
9
VP, Head Global Patient Safety & PharmacovigilanceReveal Email/Phone
10
ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$5.1M336%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M48-21%$16MN/A
#7
$1.1M70%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M5-17%N/AN/A
Add Company

What Is Athira Pharma?

Athira Pharma is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases like Alzheimer's and Parkinson's. Our innovative approach is focused on turning brain degeneration into regeneration, achieved by re-establishing lost connections and restoring lost function.

keywords:N/A

N/A

Total Funding

69

Number of Employees

$7.6M

Revenue (est)

38%

Employee Growth %

$412.7M

Valuation

N/A

Accelerator

Athira Pharma News

2022-03-30 - Latest drama at Athira: Investor calls for CEO replacement and wants two board seats

Richard Kayne. (Kayne Anderson Capital Advisors Photo). A billionaire investor of Athira Pharma is calling for the ouster of the Seattle...

2022-03-30 - Billionaire investor launches board fight at Athira, wants CEO ...

BOSTON, March 30 (Reuters) - Billionaire investor Richard (Ric) Kayne is seeking two board seats at Athira Pharma (ATHA.

2022-03-30 - Athira Pharma Highlights Strong Execution of Strategy and ...

About Athira Pharma, Inc. Athira Pharma Inc., headquartered in the Seattle area, is a late clinical-stage biopharmaceutical company focused on...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.2M696%N/A
#2
$9M69N/AN/A
#3
$13.9M6910%N/A
#4
N/A6944%N/A
#5
$11.2M698%N/A